Reuters: Health News: Actelion sees Opsumit on U.S. market this year

Actelion sees Opsumit on U.S. market this year

ZURICH (Reuters) - Europe's biggest biotech expects it new heart and lung drug Opsumit to be on sale in the United States this year if it receives app...

Source: http://feeds.reuters.com/~r/reuters/healthNews/~3/tcPGOtLly_k/us-actelion-opsumit-idUSBRE91D0BP20130214